« Previous
Next »
Contraception
Volume 79, Issue 4
, Pages
282-289
, April 2009
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
To access this article, please choose from the options below
☆ This study was funded by Schering (Berlin, Germany; now Bayer Schering Pharma).
PII: S0010-7824(08)00491-5
doi: 10.1016/j.contraception.2008.10.010
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Contraception
Volume 79, Issue 4
, Pages
282-289
, April 2009
